Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/19053
Title: Letter: dose optimising infliximab in acute severe ulcerative colitis.
Authors: Choy, Matthew C;De Cruz, Peter
Affiliation: Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Issue Date: Apr-2017
Citation: Alimentary pharmacology & therapeutics 2017; 45(8): 1169-1170
URI: http://ahro.austin.org.au/austinjspui/handle/1/19053
DOI: 10.1111/apt.13980
ORCID: 0000-0001-5206-0097
0000-0002-3399-7236
PubMed URL: 28326583
Type: Letter
Research Support, Non-U.S. Gov't
Comment
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.